{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:01:28Z","timestamp":1790085688780,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.msard.2021.103414","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T03:24:38Z","timestamp":1637205878000},"page":"103414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: Case report and systematic review"],"prefix":"10.1016","volume":"58","author":[{"given":"Chumpol","family":"Anamnart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanthaya","family":"Tisavipat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weerapat","family":"Owattanapanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metha","family":"Apiwattanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pakawee","family":"Savangned","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naraporn","family":"Prayoonwiwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasitorn","family":"Siritho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natthapon","family":"Rattanathamsakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiraporn","family":"Jitprapaikulsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2021.103414_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577236","article-title":"Risk factors of attacks in neuromyelitis optica spectrum disorders","volume":"343","author":"Akaishi","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"11","key":"10.1016\/j.msard.2021.103414_bib0002","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00415-009-5171-x","article-title":"Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution","volume":"256","author":"Bizzoco","year":"2009","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2021.103414_bib0003","doi-asserted-by":"crossref","first-page":"e702","DOI":"10.1212\/NXI.0000000000000702","article-title":"HLA association in MOG-IgG\u2013 and AQP4-IgG\u2013related disorders of the CNS in the Dutch population","volume":"7","author":"Bruijstens","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.msard.2021.103414_bib0004","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.clineuro.2016.03.023","article-title":"Recurrent optic neuritis and neuromyelitis optica-IgG following first and second human papillomavirus vaccinations","volume":"144","author":"Chang","year":"2016","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.msard.2021.103414_bib0005","article-title":"Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19","author":"Chen","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2021.103414_bib0006","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.msard.2019.01.052","article-title":"A case of neuromyelitis optica spectrum disorder following seasonal influenza vaccination","volume":"30","author":"Cho","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2021.103414_bib0007","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s13760-020-01396-1","article-title":"Neuromyelitis optica associated with yellow fever vaccination","volume":"121","author":"Esmanhotto","year":"2021","journal-title":"Acta Neurol. Belg."},{"issue":"1","key":"10.1016\/j.msard.2021.103414_bib0008","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamaneurol.2014.2137","article-title":"Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders","volume":"72","author":"Flanagan","year":"2015","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.msard.2021.103414_bib0009","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1111\/j.1468-1331.2010.03204.x","article-title":"Neuromyelitis optica after Japanese encephalitis vaccination","volume":"18","author":"Furukawa","year":"2011","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2021.103414_bib0010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000381826","article-title":"Seronegative neuromyelitis optica spectrum disorder following exposure to hepatitis b vaccination","volume":"7","author":"Heekin","year":"2015","journal-title":"Case Rep. Neurol."},{"issue":"7","key":"10.1016\/j.msard.2021.103414_bib0011","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM198702123160703","article-title":"Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination","volume":"316","author":"Hemachudha","year":"1987","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.msard.2021.103414_bib0012","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.autrev.2013.10.003","article-title":"The spectrum of post-vaccination inflammatory CNS demyelinating syndromes","volume":"13","author":"Karussis","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.msard.2021.103414_bib0013","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.24554","article-title":"Neuromyelitis optica: evaluation of 871 attacks and 1153 treatment courses","volume":"79","author":"Kleiter","year":"2016","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.msard.2021.103414_bib0014","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/archneur.1982.00510190061022","article-title":"Optic neuritis and myelitis following rubella vaccination","volume":"39","author":"Kline","year":"1982","journal-title":"Arch. Neurol."},{"issue":"1-2","key":"10.1016\/j.msard.2021.103414_bib0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jns.2010.10.013","article-title":"A serological analysis of viral and bacterial infections associated with neuromyelitis optica","volume":"300","author":"Koga","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2021.103414_bib0016","first-page":"106","article-title":"Biphasic demyelination of the nervous system following anti-rabies vaccination","volume":"52","author":"Kulkarni","year":"2004","journal-title":"Neurol. India"},{"issue":"12","key":"10.1016\/j.msard.2021.103414_bib0017","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1001\/jamaneurol.2014.2633","article-title":"Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases","volume":"71","author":"Langer-Gould","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2021.103414_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103189","article-title":"Patient-reported safety and tolerability of the COVID-19 vaccines in persons with rare neuroimmunological diseases","volume":"55","author":"Lotan","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"7","key":"10.1016\/j.msard.2021.103414_bib0019","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41562-021-01122-8","article-title":"A global database of COVID-19 vaccinations","volume":"5","author":"Mathieu","year":"2021","journal-title":"Nat. Hum. Behav."},{"issue":"3","key":"10.1016\/j.msard.2021.103414_bib0020","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1212\/WNL.0b013e31825fdead","article-title":"Neuromyelitis optica following human papillomavirus vaccination","volume":"79","author":"Menge","year":"2012","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.msard.2021.103414_bib0021","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archneur.62.11.1673","article-title":"Acute disseminated encephalomyelitis","volume":"62","author":"Menge","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2021.103414_bib0022","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.phrs.2018.04.007","article-title":"Human papillomavirus vaccine and demyelinating diseases-a systematic review and meta-analysis","volume":"132","author":"Mouchet","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.msard.2021.103414_bib0024","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jclinepi.2021.02.003","article-title":"Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement","volume":"134","author":"Page","year":"2021","journal-title":"J. Clin. Epidemiol."},{"issue":"9","key":"10.1016\/j.msard.2021.103414_bib0025","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1177\/1352458515574149","article-title":"Human leukocyte antigen association with neuromyelitis optica in a south Indian population","volume":"21","author":"Pandit","year":"2015","journal-title":"Mult. Scler."},{"issue":"5","key":"10.1016\/j.msard.2021.103414_bib0026","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1468-1331.1998.550479.x","article-title":"Neurological complications to vaccination against Japanese encephalitis","volume":"5","author":"Plesner","year":"1998","journal-title":"Eur. J. Neurol."},{"issue":"9 B","key":"10.1016\/j.msard.2021.103414_bib0027","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1590\/0004-282X20130163","article-title":"Postvaccinal neurological complications","volume":"71","author":"Rabello","year":"2013","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.msard.2021.103414_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.653786","article-title":"Acute transverse myelitis (ATM):clinical review of 43 Patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222)","volume":"12","author":"Roman","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2021.103414_bib0029","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.msard.2016.11.009","article-title":"NMOSD triggered by yellow fever vaccination - an unusual clinical presentation with segmental painful erythema","volume":"11","author":"Schoberl","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.msard.2021.103414_bib0030","first-page":"526","article-title":"A high incidence of neurological complications following semple anti-rabies vaccine","volume":"18","author":"Swaddiwudhipong","year":"1987","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"issue":"1-2","key":"10.1016\/j.msard.2021.103414_bib0031","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jneuroim.2010.11.004","article-title":"HLA-DPB1 0501 is associated with susceptibility to anti-aquaporin-4 antibodies positive neuromyelitis optica in southern Han Chinese","volume":"233","author":"Wang","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.msard.2021.103414_bib0032","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.msard.2021.103414_bib0033","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2021.103414_bib0023","unstructured":"World Health Organization (2021) Causality assessment of an adverse event following immunization (\u200eAEFI)\u200e: user manual for the revised WHO classification (2nd ed.). Available at https:\/\/www.who.int\/publications\/i\/item\/causality-assessment-aefi-user-manual-2019 [Accessed date 30 July 2021]."},{"key":"10.1016\/j.msard.2021.103414_bib0034","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.msard.2018.12.002","article-title":"Neuromyelitis optica spectrum disorder: pathogenesis, treatment, and experimental models","volume":"27","author":"Wu","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"7","key":"10.1016\/j.msard.2021.103414_bib0035","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1111\/ene.14771","article-title":"Whole-exome sequencing reveals the major genetic factors contributing to neuromyelitis optica spectrum disorder in Chinese patients with aquaporin 4-IgG seropositivity","volume":"28","author":"Zhong","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2021.103414_bib0036","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jocn.2017.10.005","article-title":"Infections in neuromyelitis optica spectrum disorder","volume":"47","author":"Zhong","year":"2018","journal-title":"J. Clin. Neurosci."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821006805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821006805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:00:23Z","timestamp":1761901223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034821006805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":36,"alternative-id":["S2211034821006805"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.103414","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: Case report and systematic review","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.103414","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103414"}}